Results 1 to 10 of about 284,324 (192)

Combination of oncolytic viruses and immune checkpoint inhibitors for treatment of high-grade gliomas [PDF]

open access: yesFrontiers in Neurology
High-grade gliomas (HGG) such as glioblastoma are the most aggressive primary malignancies of the central nervous system. The median overall survival of glioblastoma is <15 months despite treatment with surgery, radiotherapy, and chemotherapy ...
Zhihong Qian   +4 more
doaj   +2 more sources

Oncolytic Viruses in Bladder Cancer: Old Idea to Modern Approach [PDF]

open access: yesTranslational Research in Urology, 2022
Some viruses can infect and kill cancer cells. These viruses are known as oncolytic viruses (Virotherapy). The idea of killing cancer cells by oncolytic viruses mainly back to the old idea in the 19th (nineteenth) century. Scientists observed cancer cure
Kayhan Azadmanesh   +2 more
doaj   +1 more source

Oncolytic Virotherapy for Cancer: Clinical Experience

open access: yesBiomedicines, 2021
Oncolytic viruses are a new class of therapeutics which are largely in the experimental stage, with just one virus approved by the FDA thus far. While the concept of oncolytic virotherapy is not new, advancements in the fields of molecular biology and ...
Shyambabu Chaurasiya   +2 more
doaj   +1 more source

Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma

open access: yesFrontiers in Immunology, 2023
Recurrent glioma treatment is challenging due to molecular heterogeneity and treatment resistance commonly observed in these tumors. Researchers are actively pursuing new therapeutic strategies.
Mingming Hu   +7 more
doaj   +1 more source

Clinical Trials of Oncolytic Viruses in Breast Cancer

open access: yesFrontiers in Oncology, 2021
Breast cancer is the second most common kind of cancer worldwide and oncolytic viruses may offer a new treatment approach. There are three different types of oncolytic viruses used in clinical trials; (i) oncolytic viruses with natural anti-neoplastic ...
Mary E. Carter   +3 more
doaj   +1 more source

Oncolytic Viruses: Immunotherapy Drugs for Gastrointestinal Malignant Tumors

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
Oncolytic virus therapy has advanced rapidly in recent years. Natural or transgenic viruses can target tumor cells and inhibit tumor growth and metastasis in various ways without interfering with normal cell and tissue function.
Qingbo Li   +9 more
doaj   +1 more source

Study of Oncolytic Virus Preservation and Formulation

open access: yesPharmaceuticals, 2023
In recent years, oncolytic viruses (OVs) have emerged as an effective means of treating cancer. OVs have multiple oncotherapeutic functions including specifically infecting and lysing tumor cells, initiating immune cell death, attacking and destroying ...
Lina Pan   +6 more
doaj   +1 more source

Application progress of oncolytic virus combined with immunotherapy in the treatment of malignant tumors [PDF]

open access: yesZhongguo aizheng zazhi
The oncolytic virus (OV) therapy utilizes natural or genetically modified viruses to specifically target and infect tumor cells, leading to the destruction of cancer cells by the replication of the virus itself.
LIANG Yingyun, CHEN Jianhua
doaj   +3 more sources

A Three-Dimensional Organoid Model of Primary Breast Cancer to Investigate the Effects of Oncolytic Virotherapy

open access: yesFrontiers in Molecular Biosciences, 2022
Background: Although several oncolytic viruses have already been tested in early-stage clinical studies of breast cancer, there is still an urgent need to develop patient-derived experimental systems that mimic the response of breast cancer to oncolytic ...
Mary E. Carter   +9 more
doaj   +1 more source

Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptors

open access: yesMolecular Therapy: Oncolytics, 2016
To target oncolytic measles viruses (MV) to tumors, we exploit the binding specificity of designed ankyrin repeat proteins (DARPins). These DARPin-MVs have high tumor selectivity while maintaining excellent oncolytic potency.
Jan RH Hanauer   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy